Search

Your search keyword '"Gobbi, M."' showing total 78 results

Search Constraints

Start Over You searched for: Author "Gobbi, M." Remove constraint Author: "Gobbi, M." Publisher elsevier bv Remove constraint Publisher: elsevier bv
78 results on '"Gobbi, M."'

Search Results

3. Prevalence and predictive role of hypertriglyceridemia in statin-treated patients at very high risk: insights from the START Study

5. ERO1 alpha deficiency impairs angiogenesis by increasing N-glycosylation of a proangiogenic VEGFA

7. Nutritional status in post SARS-Cov2 rehabilitation patients

10. New nanostructures inhibiting human mannose binding lectin identified by a novel surface plasmon resonance assay

15. Ascites interferes with the activity of lurbinectedin and trabectedin: Potential role of their binding to alpha 1-acid glycoprotein

17. Addition of Lenalidomide to Azacitidine in Higher Risk Myelodysplastic Syndromes. Long-Term Results of a Randomized Phase II Multicenter Study

21. Age and comorbidities deeply impact on clinical outcome of patients with myelodysplastic syndromes

22. 98 CLINICAL RESPONSE TO THE ASSOCIATION OF AZACITIDINE AND LENALIDOMIDE IN HIGH-RISK MYELODYSPLASTIC SYNDROMES. A RANDOMIZED PHASE II MULTICENTER STUDY

23. 202 BOTH AGE AND COMORBIDITIES NEGATIVELY IMPACT ON CLINICAL OUTCOME OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES: RESULTS FROM A REAL-LIFE REGIONAL SURVEY

24. Differences among young adults, adults and elderly chronic myeloid leukemia patients

26. 70

27. P-294 Azacytidine therapy for MDS and AML patients: Retrospective multicentre regional experience in patients not enrolled into clinical trials

30. Long-term efficacy and toxicity results of the FLUMIZ trial (fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in untreated follicular lymphoma)

31. Mannose binding lectin as a target for cerebral ischemic injury

32. 216 Azacitidine low-dose schedule in low-risk myelodysplastic syndromes. Clinical results of a multicenter phase II study

34. 208 Iron chelation therapy with deferasirox in transfusion dependent myelodysplastic syndrome patients. Preliminary report from the prospective MDS0306 GIMEMA trial

35. A Novel High Dose Chemotherapy Strategy With Bendamustine in Adjunct to Etoposide, Cytarabine and Melphalan (BeEAM) Followed by Autologous Stem Cell Rescue Is Safe and Highly Effective for the Treatment of Resistant/Relapsed Lymphoma Patients: A Phase I-II Study on 44 Patients

37. Nanoparticles against Alzheimer's disease: PEG–PACA nanoparticles are able to link the aβ-peptide and influence its aggregation kinetic

42. OP37 Direct intra-bone injection of unrelated cord blood cells overcomes the problem of delayed engraftment or failure to engraft and improves the feasibility of hematopoietic transplant in adult patients

49. 72 Recruitment and identification of “normal” hematopoietic cells in MDS

Catalog

Books, media, physical & digital resources